Medical Device Preemption Decision May Hinge on FDA Position

-FDA News

11/06/2007- A Supreme Court decision on federal preemption authority for medical devices may hinge on the FDA’s position, and the agency has come out in favor of preemption.

The Supreme Court will hear Riegel v. Medtronic Dec. 4 to examine whether the express preemption provision of the Federal Food, Drug and Cosmetic Act (FDCA) preempts state-law claims seeking damages for injuries caused by medical devices with FDA premarket approval. The FDA has filed a brief in favor of Medtronic.

In nearly all Supreme Court cases regarding federal agency preemption, the court’s decision corresponds with the position argued by the relevant federal agency, according to Catherine Sharkey, a professor at the New York University School of Law.

Charles Riegel and his wife sued Medtronic after he was injured when a balloon catheter burst during an angioplasty procedure. Medtronic moved to dismiss the lawsuit, and a federal district court dismissed the case. It was appealed to the U.S. Court of Appeals for the Second Circuit.

Ennis & Ennis, P.A. is representing individuals that have been harmed defective medical devices such as the Medtronic defibrillator and pacemaker. If you or a loved one have suffered as a result of a defective Medtronic pacemaker or defibrillator or if you need more information about the Medtronic recall or class action lawsuit click here for a free, confidential case evaluation.